naxagolide has been researched along with buspirone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexoff, D; Carter, P; Fowler, JS; Kang, Y; Kim, D; Kim, SW; King, P; Logan, J; Muench, L; Shea, C; Skolnick, P; Volkow, ND | 1 |
Boileau, I; Di Ciano, P; Graff-Guerrero, A; Guranda, M; Houle, S; Le Foll, B; Mansouri, E; Meyer, JH; Nakajima, S; Payer, D; Tong, J; Wilson, AA | 1 |
2 other study(ies) available for naxagolide and buspirone
Article | Year |
---|---|
Therapeutic doses of buspirone block D3 receptors in the living primate brain.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Benzazepines; Benzofurans; Buspirone; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Functional Neuroimaging; Globus Pallidus; Injections, Intramuscular; Mesencephalon; Oxazines; Papio anubis; Positron-Emission Tomography; Raclopride; Radioligand Assay; Receptors, Dopamine D3 | 2014 |
Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans.
Topics: Administration, Oral; Adult; Brain; Buspirone; Carbon Radioisotopes; Dizziness; Dopamine Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Oxazines; Positron-Emission Tomography; Prolactin; Receptors, Dopamine D2; Receptors, Dopamine D3; Single-Blind Method; Sleep Stages; Young Adult | 2016 |